Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT01404585 · COMPLETED
Trial details
- NCT number
- NCT01404585
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-02-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.